ACTL6A, actin like 6A, 86

N. diseases: 46; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0018817
Disease: Atrial Septal Defects
Atrial Septal Defects
0.100 GeneticVariation group CLINVAR
CUI: C0019294
Disease: Hernia, Inguinal
Hernia, Inguinal
0.100 GeneticVariation phenotype CLINVAR
CUI: C0019322
Disease: Umbilical hernia
Umbilical hernia
0.100 GeneticVariation phenotype CLINVAR
CUI: C0039070
Disease: Syncope
Syncope
0.100 GeneticVariation phenotype CLINVAR
CUI: C0040485
Disease: Torticollis
Torticollis
0.100 GeneticVariation phenotype CLINVAR
CUI: C0426429
Disease: Broad nasal tip
Broad nasal tip
0.100 GeneticVariation phenotype CLINVAR
CUI: C0426891
Disease: Broad thumbs
Broad thumbs
0.100 GeneticVariation phenotype CLINVAR
Delayed speech and language development
0.100 GeneticVariation phenotype CLINVAR
CUI: C0747085
Disease: Recurrent otitis media
Recurrent otitis media
0.100 GeneticVariation disease CLINVAR
CUI: C1845847
Disease: Coarse facial features
Coarse facial features
0.100 GeneticVariation phenotype CLINVAR
CUI: C1859077
Disease: Aplasia/Hypoplasia of the nails
Aplasia/Hypoplasia of the nails
0.100 GeneticVariation phenotype CLINVAR
CUI: C4023295
Disease: Cleft anterior mitral valve leaflet
Cleft anterior mitral valve leaflet
0.100 GeneticVariation phenotype CLINVAR
CUI: C4317146
Disease: Acid reflux
Acid reflux
0.100 GeneticVariation phenotype CLINVAR
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.010 Biomarker disease BEFREE ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis. 28041841 2017
CUI: C0017638
Disease: Glioma
Glioma
0.020 Biomarker disease BEFREE ACTL6A promotes malignant behaviors of glioma cells in vitro and in orthotopic xenograft model. 29725063 2018
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.030 AlteredExpression phenotype BEFREE ACTL6A overexpression promoted migration and invasion of colon cancer cells, whereas ACTL6A knockdown exhibited the opposite effect in vitro. 30348114 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.020 Biomarker disease BEFREE Actin-like 6A (ACTL6A) is vital for embryogenesis and differentiation and is also critical for metastasis and EMT in hepatocellular carcinoma, as observed in our previous study. 30348114 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.030 Biomarker phenotype BEFREE ACTL6A-overexpression and ACTL6A-knockdown colon cancer cells were used to perform cytological experiments to explore the potential biological function of ACTL6A in metastasis and EMT in colon cancer. 30348114 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.020 AlteredExpression disease BEFREE A high level of ACTL6A in HCCs is correlated with aggressive clinicopathological features and is an independent poor prognostic factor for overall and disease-free survival of HCC patients. 26698646 2016
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.030 AlteredExpression phenotype BEFREE Both in vitro and in vivo assays showed that ACTL6A overexpression promoted osteosarcoma cell invasion and metastasis, whereas knockdown of ACTL6A expression reduced osteosarcoma cell malignant behavior such as invasion and metastasis. 28260090 2017
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.020 AlteredExpression phenotype BEFREE Ectopic ACTL6A/p63 expression promotes tumorigenesis, while ACTL6A expression and YAP activation are highly correlated in primary HNSCC and predict poor patient survival. 28041841 2017
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.030 Biomarker phenotype BEFREE Further functional analysis indicated that BAF53a overexpression could promote proliferation and increase the motility and invasion of U87 glioma cells, whereas BAF53a knockdown had the opposite effect. 29039584 2017
CUI: C0271907
Disease: Acquired aplastic anemia
Acquired aplastic anemia
0.010 Biomarker disease BEFREE Herein, gene expression analysis identified a significant loss of the SWI/SNF core component SMARCC1, along with ARID1B, ACTL6A, and SMARCD1, in human AA BM CD34<sup>+</sup> HSCs and hematopoietic stem and progenitor cells (HSPCs) compared with normal HSPCs. 29596882 2018
CUI: C0424605
Disease: Developmental delay (disorder)
Developmental delay (disorder)
0.300 Biomarker phenotype GENOMICS_ENGLAND Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability. 28649782 2017
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.300 Biomarker disease GENOMICS_ENGLAND Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability. 28649782 2017